Log in or Sign up for Free to view tailored content for your specialty!
Cardiometabolic Disorders News
Hot flash severity may predict metabolic-associated liver disease
BOSTON — Midlife women reporting bothersome hot flashes are more likely to receive a diagnosis of metabolic dysfunction-associated steatotic liver disease regardless of hormone therapy use, according to a speaker.
For young women, missed periods from intense stress could signal heart health risk
PHILADELPHIA — Consistently missed periods brought on by intense exercise, disordered eating or stress in young women can lead to multiple consequences, including endothelial dysfunction and increased CVD risk, according to a speaker.
Log in or Sign up for Free to view tailored content for your specialty!
Relacorilant tied to sustained cardiometabolic improvements in Cushing’s syndrome
PHILADELPHIA — Adults with Cushing’s syndrome who responded to relacorilant had sustained improvements in blood pressure and glucose levels through 34 weeks, according to findings from a phase 3 trial.
Elevated risk from diabetes in acute MI, PCI cohort not due to plaque composition
PHILADELPHIA — In patients with acute MI who had successful PCI and underwent imaging to assess plaque composition, diabetes raised risk for poor outcomes but the difference was not related to plaque, according to a presentation.
Two-step screening could prevent heart failure in diabetes with no history of CVD
PHILADELPHIA — Early, cost-effective screening may predict and prevent incident heart failure events for patients with diabetes and no prior heart disease, a speaker reported.
Osilodrostat improves comorbid hypertension, diabetes for adults with Cushing’s disease
BOSTON — Long-term osilodrostat therapy may improve symptoms of comorbid cardiometabolic disorders such as hypertension and diabetes for adults with Cushing’s disease, according to data presented at ENDO 2024.
Speaker: ‘De-risk’ patients with high Lp(a) to prevent atherosclerotic events
PHILADELPHIA — Despite there being few options to directly lower lipoprotein(a) as of yet, measurement is none the less important to identify those who would benefit from improved risk factor control, a speaker reported.
VIDEO: Spotlight on ‘worsening trend’ of heart attack and cardiovascular death in young women
PHILADELPHIA — In this Healio video exclusive, Erin D. Michos, MD, MHS, FAHA, FACC, FASE, FASPC, highlights the need for greater prevention of myocardial infarction and cardiovascular death in young women.
FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin
The FDA granted clearance for two new over-the-counter continuous glucose monitoring systems, one for adults with type 2 diabetes who do not use insulin and another for adults without diabetes, according to an industry press release.
Task force updates multispecialty guidance for diabetes, cardiorenal and metabolic diseases
PHILADELPHIA — A task force has issued an updated multispeciality guide to help clinicians manage diabetes, cardiorenal and metabolic diseases.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read